Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for ICON PLC (ICLR : NSDQ)
 
 • Company Description   
ICON plc is a global full service clinical research organisation. The company provides contract clinical research services to the pharmaceutical industry worldwide.

Number of Employees: 40,100

 
 • Price / Volume Information   
Yesterday's Closing Price: $165.76 Daily Weekly Monthly
20 Day Moving Average: 714,114 shares
Shares Outstanding: 76.57 (millions)
Market Capitalization: $12,691.75 (millions)
Beta: 1.22
52 Week High: $203.91
52 Week Low: $66.57
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 2.98% 2.23%
12 Week 40.08% 36.25%
Year To Date -9.03% -13.63%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
SOUTH COUNTY BUSINESS PARK LEOPARDSTOWN
-
DUBLIN 18,L2 00000
IRL
ph: 353-1291-2000
fax: 353-1247-6260
None http://www.iconplc.com
 
 • General Corporate Information   
Officers
Steve Cutler - Chief Executive Officer and Director
Ciaran Murray - Chair and Director
Barry Balfe - Chief Operating Officer
Nigel Clerkin - Chief Financial Officer
Ronan Murphy - Lead Independent Director

Peer Information
ICON PLC (CHCR)
ICON PLC (ESRX)
ICON PLC (MYDP)
ICON PLC (COR)
ICON PLC (GBCS)
ICON PLC (LAXAF)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Medical Services
Sector: Medical
CUSIP: G4705A100
SIC: 8731
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/26
Next Expected EPS Date: 07/29/26
Share - Related Items
Shares Outstanding: 76.57
Most Recent Split Date: 8.00 (2.00:1)
Beta: 1.22
Market Capitalization: $12,691.75 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $2.39 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $9.43 Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: 6.00 Change In Payout Ratio: 0.00
Estmated Long-Term EPS Growth Rate: 2.16% Last Dividend Paid: NA - $0.00
Next EPS Report Date: 07/29/26  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 17.57
Trailing 12 Months: 15.91
PEG Ratio: 8.14
Price Ratios
Price/Book: 1.36
Price/Cash Flow: 9.84
Price / Sales: 1.55
EPS Growth
vs. Year Ago Period: -27.69%
vs. Previous Quarter: 0.45%
Sales Growth
vs. Year Ago Period: 1.63%
vs. Previous Quarter: -3.72%
ROE
06/30/26 - -
03/31/26 - 8.73
12/31/25 - 9.50
ROA
06/30/26 - -
03/31/26 - 4.96
12/31/25 - 5.40
Current Ratio
06/30/26 - -
03/31/26 - 1.14
12/31/25 - 1.10
Quick Ratio
06/30/26 - -
03/31/26 - 1.14
12/31/25 - 1.10
Operating Margin
06/30/26 - -
03/31/26 - 9.94
12/31/25 - 10.92
Net Margin
06/30/26 - -
03/31/26 - 5.35
12/31/25 - 5.98
Pre-Tax Margin
06/30/26 - -
03/31/26 - 2.42
12/31/25 - 3.06
Book Value
06/30/26 - -
03/31/26 - 121.47
12/31/25 - 120.07
Inventory Turnover
06/30/26 - -
03/31/26 - -
12/31/25 - -
Debt-to-Equity
06/30/26 - -
03/31/26 - 0.31
12/31/25 - 0.31
Debt-to-Capital
06/30/26 - -
03/31/26 - 23.56
12/31/25 - 23.81
 

Powered by Zacks Investment Research ©